CClinicalTrials.gg
CompletedNCT04835103Updated Jan 20, 2025

Build a Research Clinic for Somatoform Patients

An interventional study of CM and P/T in Somatoform Disorders and Somatic Symptom Disorder, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 15 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-01-20.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Non-randomized
Ages
15 Years to 80 Years
Sex
All
01

Study summary

To investigate the effects of the two following interventions on somatoform patients:1. case management model2. psychotherapy, based on cognitive-behavioral therapy and biofeedback therapy

Read the detailed description

Patients with presentations of somatic symptoms and associated psychological features are named as "somatoform disorders" in psychiatric field. Because the patients' concerns are somatic distress, they often seek help in non-psychiatric clinics. However, the symptoms are usually medically unexplained. This group of diagnoses can be managed from the psychiatric perspective, including medications and psychotherapies. However, many patients do not receive psychiatric management in current medical practice. The goal of this project is to establish an association named "psychosomatic center" for providing comprehensive evaluations and treatments to the somatoform patients. Besides the psychiatrist, a case manager, a clinical psychologist, and a research assistant will be included in this association for the purposes of connection, performing psychotherapy and examinations. After entering the psychosomatic clinic, the investigators will routinely perform diagnostic interview, measure psychological and physiological features, and arrange individualized treatment program. The investigators will follow the important psychological and biological indexes every 3-6 months for building a cohort. At the same time, the case manager will connect with non-psychiatric clinics for ensuring the patients physical problems to be managed. The investigators expect this project to enhance the quality of treatment on the patients, to reduce the excessive examinations for the frequent attenders, and to improve the emotional burden of medical staffs.

02

Conditions studied

  • Somatoform Disorders
  • Somatic Symptom Disorder

Keywords

  • somatoform disorders
  • somatic symptom disorder
  • psychosomatic medicine
  • medically unexplained symptoms
03

Who can participate

Ages eligible
15 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    1. Between 15 and 80 years old
    1. Meet the diagnosis of DSM-5 somatic symptom disorder

Exclusion criteria

Exclusion Criteria:

    1. With psychotic symptoms (such as schizophrenia, bipolar disorder with psychotic symptoms) or cognitive impairment
    1. Having potentially lethal physical diseases (such as cancer, coronary artery diseases, cerebrovascular diseases; because under this condition, high health anxiety is quite rational. Patients with common physical diseases can still enter this trial)
    1. Unable to read or understand the questionnaires
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,000 participants (actual)

Study arms

  • Other
    Set a case management model for somatoform patients

    Somatoform patients receiving case management, single group assignment, open label

    Behavioral: CM

  • Other
    Time-limited psychotherapy for somatoform patients

    Somatoform patients receiving psychotherapy (based on cognitive-behavioral therapy and biofeedback therapy) vs treatment as usual, open label, non-randomized

    Behavioral: P/T

Interventions

  • BehavioralCM

    Case management, a case manager will actively contact and follow the patient's physical and psychological conditions, and provide disease-specific psychoeducation

  • BehavioralP/T

    Psychotherapy, based on both cognitive-behavioral therapy and biofeedback therapy, structuralized, 6-10 sessions, performed by a psychiatrist or psychologist

05

What researchers measure

Primary outcomes

  1. Changes from baseline Patient Health Questionnaire-15 (PHQ-15) score at 3 months and 6 months (for psychotherapy); changes from baseline PHQ-15 score at 3, 6, 12, 24 months (for case management)

    PHQ-15 is a scale rating the severity of somatic distress. It is a 3-point Likert scale with 15 items. The scores range from 0 (lowest level of somatic distress) to 30 (highest level of somatic distress).

    Time frame: 3, 6 months after initiating psychotherapy (for psychotherapy); 3, 6, 12, 24 months after initiating case management (for case management)

  2. Changes from baseline Health Anxiety Questionnaire (HAQ) score at 3 months and 6 months (for psychotherapy); changes from baseline HAQ score at 3, 6, 12, 24 months (for case management)

    HAQ is a scale rating the severity of health anxiety. It is a 4-point Likert scale with 21 items. The scores range from 0 (lowest level of health anxiety) to 63 (highest level of health anxiety).

    Time frame: 3, 6 months after initiating psychotherapy (for psychotherapy); 3, 6, 12, 24 months after initiating case management (for case management)

Secondary outcomes

  1. Scores of Scale for the Assessment of Illness Behavior (SAIB)

    SAIB is a scale rating the illness behavior. It is a 4-point Likert scale with 25 items. The scores range from 0 to 75.

    Time frame: 3, 6, 12, 24 months

  2. Scores of Cognition About Body and Health Questionnaire (CABAH)

    CABAH is a scale rating the cognition about health anxiety. It is a 4-point Likert scale with 39 items. The scores range from 0 to 117.

    Time frame: 3, 6, 12, 24 months

  3. Scores of Beck Depression Inventory-II (BDI- II)

    BDI- II is a scale rating the severity of depression. It is a 4-point Likert scale with 21 items. The scores range from 0 (lowest level of depression) to 63 (highest level of depression).

    Time frame: 3, 6, 12, 24 months

  4. Scores of Beck Anxiety Inventory (BAI)

    BAI- II is a scale rating the severity of anxiety. It is a 4-point Likert scale with 21 items. The scores range from 0 (lowest level of anxiety) to 63 (highest level of anxiety).

    Time frame: 3, 6, 12, 24 months

  5. Penn State Worry Questionnaire (PSWQ)

    PSWQ-16 is a scale rating the severity of worry. It is 5-point Likert scale with 16 items. The scores range from 1 (lowest level of worry) to 80 (highest level of worry).

    Time frame: 3, 6, 12, 24 months

  6. Scores of WHOQOL-BREF

    It is a self-report questionnaire measuring health-related quality of life. It is a 4-point Likert scale with 28 items, which belong to 5 domains (the overall, physical, psychological, social and environmental domains). The scores of each domain are usually normalized with 0-20 or 0-100.

    Time frame: 3, 6, 12, 24 months

  7. Changes from baseline standard deviation of normal to normal RR intervals (SDNN)

    SDNN reflects all the cyclic components responsible for variability in the period of recording, therefore it represents total variability.

    Time frame: 3, 6, 12, 24 months

  8. Changes from baseline high-frequency power (HF)

    HF component of HRV represents parasympathetic activity.

    Time frame: 3, 6, 12, 24 months

  9. Changes from baseline ratio of low-frequency power to high-frequency power (LF/HF)

    LF/HF was considered to reflect sympathovagal balance by some scholars.

    Time frame: 3, 6, 12, 24 months

  10. Changes from baseline value of skin conductance.

    In skin conductance, an electrodermograph imposes an imperceptible current across the skin and measures how easily it travels through the skin. Skin conductance is usually considered as a biomarker of sympathetic activity.

    Time frame: 3, 6, 12, 24 months

  11. Changes from baseline value of Respiratory sinus arrhythmia

    Respiratory sinus arrhythmia is an index combining the heart rate and respiratory signal, it represents parasympathetic activity.

    Time frame: 3, 6, 12, 24 months

  12. Changes from baseline value of Finger temperature.

    Finger temperature is found to be related to emotional disturbance (such as depression and anxiety), and it is often used in biofeedback therapy.

    Time frame: 3, 6, 12, 24 months

  13. Changes from baseline value of electromyogram

    Electromyogram is found to be related to emotional disturbance (such as depression and anxiety), and it is often used in biofeedback therapy.

    Time frame: 3, 6, 12, 24 months

06

Study locations

1 site
  • Department of Psychiatry, National Taiwan University Hospital Yunlin Branch
    Douliu, Taiwan
07

Registry details

Key details

Study ID
NCT04835103
Lead sponsor
National Taiwan University Hospital
Collaborators
National Taiwan University Hospital, Yun-Lin Branch
Responsible party
Sponsor
First posted
Apr 8, 2021
Start date
Jul 9, 2021
Primary completion
Jan 24, 2024
Completion
Mar 14, 2024
Last update
Jan 20, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion